Dong-A Socio Holdings announced on the 7th that it has been selected as one of the ‘Top 100 ESG Companies for the First Half of 2025’ by Sustinvest, a domestic ESG (Environment, Social, Governance) evaluation agency.
Sustinvest conducts ESG evaluations twice a year for about 1,300 listed and unlisted companies. The results are used as investment decision indicators by major institutional investors such as the National Pension Service. Based on asset size, the top 100 ESG companies are selected, with categories including: ▲50 companies with assets over 2 trillion won ▲30 companies with assets between 500 billion and 2 trillion won ▲20 companies with assets under 500 billion won.
In this first half evaluation, Dong-A Socio Holdings was included in the group with assets over 2 trillion won for the first time and received an A grade in this group. In the second half of last year, it received an AA grade in the group with assets between 500 billion and 2 trillion won.
The subsidiary Dong-A ST, which handles prescription pharmaceuticals, and ST Pharm, responsible for the raw material pharmaceuticals business, were also selected consecutively as top 100 companies. Notably, Dong-A ST rose sharply from 27th to 4th place, and ST Pharm jumped from 30th to 8th place.
Both companies published their first sustainable management report this year, revealing their financial and non-financial performance in a structured manner. The evaluation agency seems to have given high marks for this transparency.
A representative from Dong-A Socio Holdings said, “We will continue with innovation and responsible management for a sustainable future” and “We aim to lead positive change based on collaboration with customers, the local community, and stakeholders.”